Kristin Oaks, DO, Agilon regional medical director at Central Ohio Primary Care, spoke at our recent Institute for Value-Based Medicine® event held with Zangmeister Cancer Center. Here, she addresses the importance of value-based care within the primary care space.
Kristin Oaks, DO, Agilon regional medical director at Central Ohio Primary Care, spoke at our recent Institute for Value-Based Medicine® event held with Zangmeister Cancer Center. In this clip from our interview, she addresses the importance of value-based care within the primary care space.
Transcript
Can you discuss your presentation, “Value-Based Care: What Is It and Why Should We Care?”
I spoke about how we, as a primary care group, think about our empaneled patients in a value-based care approach. Value-based care is kind of 2 things. One is it's the payment model that we function under as primary care physicians in this particular population, in our senior-based care. And I think there's also the way that we provide that care and what we do differently now that we have this other model that we're paid via. Some of that is really around how we empanel our patients, how we've changed inside our organization to increase our access for those patients, to have high-quality visits for those patients, and to work outside the organization with specialists and hospitalists on what happens to our patients outside of the exam room.
What are key principles and components of value-based care, especially as they relate to primary care–related outcomes?
In primary care, we think about the totality of our care, right? That includes what other folks are doing, what we're doing. Some of that is just making sure that we understand what preventable disease exists in our patients. That’s the foundation of primary care anyway.
Some of it is, we have that longitudinal relationship with our patients that a lot of specialists don't enjoy. If we really understand the basis of the patient's chronic illnesses, as well as how to optimize the care of those illnesses, both from our side and specialist side, that’s a key component of value-based care. Additionally, having that access to the value-based care payment model allows us to develop programs that really support our patients at our practice.
We at Central Ohio Primary Care have after-hours support for our patients until 11 o'clock, including televisits. We have our own partners working in the same-day center, with hospitalists on duty that can give fluids and fusions and that sort of thing. We have a really robust care management team. We have our own palliative team and home-visiting physicians. So it has really allowed us support our sickest patients where needed and then keep our healthier patients healthier.
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
House lawmakers are expected to advance a contracting ban today on 5 Chinese research firms; US government officials temporarily relaxed strict guidelines on how laboratories handle, store, and transport H5N1 bird flu samples; a recent report found that the number of abortions occurring in the US continued to grow despite bans.
Read More
Patients With MG Report Higher Azathioprine Discontinuation vs Other Immunosuppressants
May 15th 2024Survey data from over 200 patients showed that treatment discontinuation was lower for those taking mycophenolate or methotrexate than for those taking azathioprine for their myasthenia gravis (MG).
Read More